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ABSTRACT 
Variants in the microglial receptor TREM2 confer risk for multiple neurodegenerative diseases. However, 
it remains unknown how this receptor functions on microglia to modulate these diverse 
neuropathologies. In order to understand the role of TREM2 on microglia more generally, we 
investigated changes in microglial function in Trem2-/- mice. We found that loss of TREM2 impairs normal 
neurodevelopment, resulting in reduced synapse number across the cortex and hippocampus in 1-
month-old mice. This reduction in synapse number was not due directly to alterations in interactions 
between microglia and synapses. Rather, TREM2 was required for microglia to limit synaptic engulfment 
by astrocytes during development. While these changes were largely normalized later in adulthood, high 
fat diet administration was sufficient to reinitiate TREM2-dependent modulation of synapse loss. 
Together, this identifies a novel role for microglia in instructing synaptic pruning by astrocytes to broadly 
regulate appropriate synaptic refinement, and suggests novel candidate mechanisms for how TREM2 
and microglia could influence synaptic loss in brain injury and disease. 
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INTRODUCTION  
Our understanding of microglial function in health (Kierdorf & Prinz, 2017) and disease (Hickman et al., 
2018) has greatly advanced in recent years. Microglia have long been implicated in the pathology of 
neurodegenerative diseases (NDDs) (Kreutzberg, 1996). However, human genetic studies have only 
recently provided definitive evidence that microglial dysfunction can actively modulate NDD pathogenesis 
and progression (Efthymiou & Goate, 2017; Karch & Goate, 2015; Ransohoff, 2016), with the identification 
of TREM2 variants associated with high risk for developing Alzheimer’s disease (AD) (Guerreiro et al., 
2013; Jonsson et al., 2013). Because the TREM2 receptor is exclusively expressed on microglia in the brain  
(Jay, von Saucken, & Landreth, 2017), association of TREM2 variants with AD demonstrates that microglia 
can play an active role in modulating AD pathology. Since the identification of these variants, a multitude 
of studies have attempted to elucidate TREM2’s role in AD in order to gain insight into key microglial 
functions in disease. These studies have largely focused on the role of TREM2 in mediating microglial 
responses to amyloid plaques, identifying that TREM2 can bind to Aβ peptides (Lessard et al., 2018; Zhao 
et al., 2018; Zhong et al., 2018) and is required for microglia to accumulate around amyloid plaques (Jay et 
al., 2015; Ulrich et al., 2014; Wang et al., 2015; Yuan et al., 2016), phagocytose Aβ (Jay et al., 2017; Jiang 
et al., 2014; Kleinberger et al., 2014; Melchior et al., 2010; Parhizkar et al., 2019; Wang et al., 2016; Yuan 
et al., 2016) and engage in Aβ-driven phenotypic changes in mouse models of AD (Jay et al., 2015; Keren-
Shaul et al., 2017; Wang et al., 2015). While these may represent important functions of TREM2 in AD, 
TREM2 variants have now also been associated with risk for developing frontotemporal dementia and 
Parkinson’s disease (Jay, von Saucken, & Landreth, 2017), and are the genetic cause of Nasu Hakola 
disease (also termed polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy, 
PLOSL) (Paloneva et al., 2002), a progressive neurodegenerative disease characterized by white matter 
loss, psychosis and dementia (Hakola, 1972; Nasu, Tsukahara, & Terayama, 1973). The neuropathological 
features of these diseases are quite diverse, demonstrating that TREM2’s essential role in 
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neurodegeneration cannot simply be to coordinate amyloid recognition or responses. Indeed, Trem2 was 
found to be part of a genetic signature that defines a subset of microglia present in many NDD contexts 
(Krasemann et al., 2017). Thus, it is likely that TREM2 serves a broader role on microglia, regulating 
functions of these cells that converge on common features of brain injury and disease.  
 Recently, the similarities between microglial roles in neurodegeneration and normal brain 
development have begun to be appreciated. Complement proteins, for example, were previously known 
to mediate microglial elimination of supernumerary synapses which are produced during initial stages of 
brain development (Schafer et al., 2012; Stevens et al., 2007). Complement has also been implicated in 
microglial elimination of synapses in AD, mediating pathological loss of synapses in AD mouse models 
(Hong et al., 2016; Shi et al., 2017). Complement is also involved in synaptic loss in response to acute brain 
injury (Alawieh et al., 2018; Norris et al., 2018), chronic tau accumulation (Dejanovic et al., 2018), epilepsy 
(Wyatt et al., 2017), neuroinflammation (Watkins et al., 2016) and other disease contexts (Sekar et al., 
2016). Other microglial signaling components also have important functions in both brain development 
and neurodegeneration, including CX3CR1 (Basilico et al., 2019; Paolicelli et al., 2011; Sheridan & Murphy, 
2013) and progranulin (Baker et al., 2006; Lui et al., 2016), further illustrating that common mechanisms 
can mediate important microglial functions in brain health and disease (Tenner, Stevens, & Woodruff, 
2018).  
 Evidence already indicates that TREM2 may also have roles in microglial regulation of normal 
brain development. Patients with the TREM2-related genetic disorder PLOSL begin to exhibit neurological 
symptoms in their 20’s (Kaneko et al., 2010). This age of onset coincides with a late adolescent period of 
developmental synaptic pruning (Keshavan, Anderson, & Pettegrew, 1994), suggesting the possibility that 
TREM2 could normally play a role in regulating that process. In support of this, recent work has identified 
changes in brain circuitry of TREM2 deficient mice at P20, a time point which similarly follows a period of 
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heightened synaptic refinement (Filipello et al., 2018). Even studies of individuals who carry TREM2 
variants associated with NDDs with typical onset in late adulthood have found changes in brain volume 
(Luis et al., 2014) and cognitive function (Jonsson et al., 2013; Montalbetti et al., 2005) even decades 
before these individuals exhibit clinical manifestations of disease. These data argue that microglial-driven 
changes in brain function that occur far earlier in development can influence later NDD pathogenesis. 
 If TREM2 does have functional roles in the healthy brain, it could provide a genetic starting point 
to expand our understanding of normal microglial functions, as it has already provided important insights 
into roles of microglia in disease. We do not know how broadly microglia are involved in the essential 
function of synaptic elimination in nervous system development, whether they interact with other cell 
populations to mediate appropriate synaptic refinement, or the extent of diversity in the mechanisms that 
these cells use to engage in circuit remodeling at different times and in different circuits.  
We assessed the function of TREM2 in neurodevelopment to identify novel roles for microglia in 
the healthy brain. We found that microglia are critical for shaping neurodevelopement quite broadly, with 
distinct roles in different cortical and hippocampal regions. Perturbing TREM2 function in microglia led to 
enhanced synaptic uptake by astrocytes. Together, this study identifies a broad requirement for microglia 
in appropriately establishing and modifying synapses, finds a novel, TREM2-dependent mechanism for 
these changes, and establishes that microglia instruct other glial populations to appropriately shape 
synaptic connections in development and adulthood.     
 
METHODS 
Mice 
Trem2-/- mice (TREM2tm1(KOMP)Vlcg) express a lacZ reporter in place of exons 2, 3 and part of 4 and were 
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previously validated to lack TREM2 expression (Jay et al., 2015). Littermate controls of both sexes, all 
maintained on a B6/SJL background, were used in all experiments. Electrophysiology experiments were 
performed on mice housed at the Stark Neurosciences Research Institute at Indiana University and 
procedures were approved by the IU School of Medicine IACUC committee. Mice used for all other 
experiments were housed in the animal facility at Case Western Reserve University and approved by the 
Case Western Reserve University IACUC committee. All mice had ad libitum access to food and water. 
Where indicated, mice received a high fat diet (Harlan-Tekland 7960) from 1-4 months of age. 
 
Synaptosome isolation 
Synaptosomes were isolated (Dunkley, Jarvie, & Robinson, 2008) and prepared as previously described 
(Chung et al., 2013). Briefly, mice were anesthetized with isoflurane, decapitated and their brains 
removed and homogenized in 3mL gradient buffer (320mM sucrose, 1.2mM EDTA, 5mM Tris, pH7.4) for 
1.25min using a mechanical homogenizer. This solution was centrifuged in 12mL polycarbonate tubes in a 
J20 rotor at 3,600rpm for 10min at 4°C. The supernatant (S1 fraction) was divided and reserved for 
Western blot analysis and the remainder diluted to 4-5mg/mL protein. 2mL of this fraction was layered 
over a 3% / 10% / 15%  / 23% discontinuous percoll (GE Healthcare 17089101) gradient prepared in 
gradient buffer and centrifuged at 20,000rpm for 5min at 4°C with the lowest deceleration setting. 
Fraction 4 at the interface of 3% and 10% gradients and fraction 3 taken at the interface of 10% and 15% 
gradients were collected, diluted in gradient buffer and centrifuged at 16,000rpm for 20min at 4°C. The 
pellet was washed and resuspended in 0.1M sodium carbonate pH 9.0 at a concentration of 5mg/mL. An 
aliquot from each sample was reserved for Western blot analysis, and the remainder labeled with 137nM 
concentration of pHrodo Red succinimidyl ester (Thermo Fischer P36600) by shaking at room temperature 
for 2hr at 120rpm. Conjugated synaptosomes were washed in PBS, resuspended in PBS with 5% DMSO 
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and frozen slowly in a Styrofoam container at -20°C. Before use, synaptosomes were rapidly thawed at 
37°C, counted on a hemocytometer, and diluted to a final concentration of 10,000 synaptosomes/mL in 
serum free DMEM/F12 media.   
 
Protein isolation and western blots 
To obtain cortical and hippocampal lysates, mice were perfused with PBS, cortices and hippocampi 
dissected and snap frozen on dry ice. Brains were homogenized in PBS with 1% NP-40, 0.5% sodium 
deoxycholate and 0.1% SDS, sonicated and centrifuged. Protein from synaptosomal fractions was 
prepared as described above. Protein concentration was determined using a BCA kit (Thermo Scientific). 
Proteins were boiled for 5min at 95°C in sample buffer containing DTT. 25μg of protein per sample for 
cortical and hippocampal lysates and 2μg of protein for synaptosome enriched fractions were 
loaded into 4-12% Bis-Tris gels (Life Technologies) and run at 100V in MOPS running buffer. Protein was 
transferred onto IR-compatible PVDF membranes on ice in a Tris glycine buffer containing methanol at 
100V for 1hr. Membranes were blocked in TBS Odyssey Blocking Buffer diluted 1:1 with TBS for 1 hour 
at room temperature and incubated with the indicated primary antibodies in blocking buffer overnight 
at 4°C: Actin (Santa Cruz sc-1615, 1:5000), C1q (Abcam ab182451), Gas6 (R&D AF986, 1:10000), GAPDH 
(Santa Cruz sc-32233, 1:10000), HDAC1 (Abcam ab19845, 1:1000), Histone H3 (Abcam ab1791, 1:2500), 
Na+K+ATPase (Abcam ab76020, 1:5000), NR2A (Millipore 07-632, 1:2000), NR2B (Millipore 06-600, 
1:2000), Protein S (R&D MAB4976, 1:350), PSD95 (Invitrogen MA1-046, 1:2000), Synapsin (Abcam 
ab64581, 1:1000), or Synaptophysin (Abcam ab16659, 1:5000). Membranes were washed in TBS and 
incubated in a 1:10,000 dilution of the appropriate IR dye conjugated secondary antibody in blocking 
buffer for 1 hour at room temperature. Membranes were imaged and analyzed using the Odyssey 
imaging system. Each sample was normalized to actin or GAPDH as indicated and the graphs represent 
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these values normalized to the mean of the Trem2+/+ group. 
 
ELISAs  
Protein was isolated as previously described and concentration determined using a BCA kit (Thermo 
Scientific). Each sample was diluted to a final concentration of 2mg/mL. Assays were otherwise performed 
using the reagents and instructions provided in the Quantikine ELISA Mouse M-CSF (R&D MMC00) and 
Quantikine ELISA Mouse IL-34 (R&D M3400) kits. Plates were imaged using a BioTek Synergy HTX plate 
reader and analyzed as instructed. 
 
RNA isolation and qPCR 
Homogenized brain lysates were prepared as described above and added to an equal volume of RNA-Bee 
before storing at -80°C until use. RNA was isolated using chloroform extraction and purified using the 
Purelink RNA Mini Kit (Life Technologies). Samples were treated with an on-column DNAse Purelink kit (Life 
Technologies). cDNA was prepared from 250ng - 1μg of RNA using a QuantiTech Reverse Transcription kit 
(Qiagen) and qPCR performed using the StepOne Plus Real Time PCR system (Life Technologies) with 
Taqman assays. Relative gene expression was assessed relative to GAPDH or cell-type specific controls as 
indicated. Data are graphed as fold change gene expression and ΔCT values were used for statistical 
comparisons. 
 
Slice preparation and immunohistochemistry 
Mice were perfused with PBS, brains removed and one hemisphere drop fixed in 4% PFA at 4°C overnight 
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and cryoprotected in 30% sucrose before snap freezing in OCT. Brains were cryosectioned into 30μm free 
floating sections and were stored in cryoprotectant buffer at -20°C until use. Slices were permeabilized in 
PBS with 0.1% Triton-X and antigen retrieval was performed using 10mM sodium citrate with 0.5% Tween 
pH 6.0 at 85°C for 15min and then at room temperature for 30min. Slices were blocked (5% Normal 
Donkey Serum, 0.3% TritonX-100 in PBS pH7.4) for 1hr and then incubated in the following primary 
antibodies overnight at 4°C: Aldhl1 (Abcam ab87117, 1:250), GFAP (Abcam ab7260, 1:1000), Iba1 (Wako 
019-19741, 1:500), PSD95 (Millipore MAB1596, 1:100 - 1:200) or synaptophysin (Cell Signaling 5461, 
1:1000). Slices were incubated with Alexa-fluor conjugated secondary antibodies at a 1:1000 
concentration for 1hr at room temperature, stained with a 1:10000 concentration of DAPI in PBS, washed 
and mounted using Prolong Gold.  
 
Image Acquisition and Analysis 
Synapse Number 
Immunohistochemistry for synaptophysin and PSD95 was performed as described above on 3 medial 
sections per animal. Confocal images were acquired at 63x and optical slices were acquired at the center 
of each slice spanning 0.5μm of tissue. Maximum projections were obtained from these z stacks, 
correcting for photobleaching by normalizing the signal to the average signal of each slice. Images were 
thresholded based on secondary only controls run with each experiment. For analyses at 1 month of age, 
the number of each synaptic element was quantified using General Analysis on NIS AR Software (Nikon) 
and apposed synaptic elements determined by using the “min distance” function with a distance 0.5μm. 
For analyses at 4 months of age, the number of synaptic elements and apposed synaptic elements within 
0.5μm was determined using the puncta analyzer plugin for ImageJ (Ippolito & Eroglu, 2010). For each 
animal, at least 3 images were analyzed per slice for each region and results were averaged to generate 
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each replicate used in the analysis. 
 
Microglial density and territory 
Immunohistochemistry was performed for Iba1 on 1 medial and 1 lateral sagittal brain section for each 
animal and images were acquired on a Hamamatsu Nanozoomer S60 slide scanner. DAPI was used to 
define brain regions of interest and Iba1+ cells were manually counted within each region in ImageJ. The 
number of cells was normalized to the area of each region counted to yield the reported microglial 
number / area. The cell bodies identified were also analyzed using the Delaunay/Voronoi plugin for 
ImageJ. The results of the Voronoi tessellations were thresholded and the area of each cell determined. 
Those located on the edges were excluded from the analysis. The average area defined by the 
tessellations are reported as mean territory. The variation of the territories was analyzed in GraphPad 
Prism in which column analyses were used to determine the coefficient of variance of the territories 
defined for each region for each animal. These are reported as territory variance. 
 
Microglial morphology 
Sholl analyses on microglia were performed as previously described with minor modifications (Norris, 
Derecki, & Kipnis, 2014). Briefly, 3 medial sections per animal were stained for Iba1 and 63x confocal 
images were acquired with optical slices set at 1 AU across the 30μm sections. Images were thresholded 
and maximum projections were prepared from z stacks. Any extraneous signal was manually erased. 
Because cell body size was found to be different between Trem2+/+ and Trem2-/- microglia (data not 
shown), the Sholl analysis protocol was modified such that the experimenter defined the longest distance 
across the cell body and the first radius of the Sholl analysis was set to start 1μm away from that distance. 
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Subsequent radii were defined 5μm apart as previously described and the results reported as calculated 
by the Sholl analysis plugin for ImageJ.   
 The hull and circle algorithm was also used to assess microglial morphology. The hull and circle 
plugin for ImageJ defines the smallest convex hull which contains the entirety of each microglia’s 
processes, and further defines a circle that circumscribes that convex hull. The measures are reported as 
calculated by the hull and circle plugin. Cellular replicates were used across all analyses of microglial 
morphology. 
 
Engulfment of PSD95 in microglia and astrocytes 
Iba1 and PSD95 immunohistochemistry was performed on 1 medial and 1 lateral slice per animal. Z stacks 
were acquired at 63x with 1 AU z steps through the 30μm tissue. Individual microglia were isolated from 
each image and cells thresholded. PSD95 was thresholded based on secondary only controls run with each 
experiment and the PSD95 within the thresholded area of each cell was quantified. Volume was 
calculated by multiplying the area within each image by the z step value. Results are reported as the 
PSD95 volume within Iba1+ microglia divided by cell volume, multiplied by 100. 
A similar procedure was used to quantify synaptic material in astrocytes from slices stained with 
Aldhl1 and PSD95. However, because of the extent of astrocyte processes, it was not possible to isolate 
individual astrocytes and so a similar analysis was performed as described above but across each 63x field.  
For analyses that compared PSD95 uptake by microglia and astrocytes, volume of astrocytes was 
reported from the analysis described above. For microglia, the analysis above was repeated using the 
same protocol used for astrocytes, quantifying volume of glia and PSD95 volume within a given imaging 
field rather than for individual cells. Cellular replicates were used for statistical analyses of PSD95 
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engulfment. 
 
Electrophysiology 
1-1.5-month-old mice were anesthetized using isoflurane and sacrificed by rapid decapitation. The brain was 
removed, placed in an ice-cold cutting solution (194mM sucrose, 30mM NaCl, 4.5mM KCl, 1mM MgCl2, 
26mM NaHCO3, 1.2mM NaH2PO4, 10mM glucose) saturated with 95% O2 and 5% CO2, and 280μm slices 
were prepared using a vibratome (Leica VT1200S). Slices were transferred to artificial cerebral spinal fluid 
(aCSF: 124mM NaCl, 4.5mM KCl, 1mM MgCl2, 26mM NaHCO3, 1.2mM NaH2PO4, 10mM glucose, 2mM CaCl2) 
saturated with 95% O2 and 5% CO2 at 30°C for 1 hour and then kept at room temperature until recording. 
For recording, brain slices were transferred to a chamber that was continuously perfused with aCSF 
containing 0.5μM TTX and 50μM picrotoxin at a rate of 1-2mL/min in 5% CO2 at 29-32°C and visualized using 
an Olympus BX51WI microscope (Olympus Corporation of America).  Whole cell voltage clamp recordings 
were performed using a Multiclamp 700B amplifier (Molecular Devices). Hippocampal CA1 neurons were 
patch clamped using filament-containing borosilicate micropipettes (World Precision Instruments) using a P-
1000 micropipette puller (Sutter Instruments) with a 2-4 MΩ resistance filled with 120mM CsMeSO3, 5mM 
NaCl, 10mM TEA-Cl, 10mM HEPES, 5mM lidocaine bromide, 1.1mM EGTA, 0.3mM Na-GTP and 4mM Mg-
ATP, pH 7.2. Voltage was held at -60mV and miniature excitatory postsynaptic currents (mEPSCs) were 
acquired across a 3min time window using pClamp 10.3 software (Molecular Devices). Only cells with a 
series resistance less than 25 MΩ that did not change more than 15% during recording were included for 
data analysis. mEPSCs analysis was performed using MiniAnalysis 6.0 (Synaptosoft Inc). Recordings from 
slices prepared from Trem2+/+ and Trem2-/- littermates were acquired in the same recording session in 
randomized order and the experimenter was blinded to genotype. Each n represents a cell, which were 
recorded from 3 animals of each genotype. 
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In vitro preparation of microglia and astrocytes 
P2 Trem2+/+ and Trem2-/- littermates were sacrificed by decapitation, brains were removed and washed in 
PBS with glucose. Brains were dissociated in 0.05% Trypsin in EDTA for 20min at 37°C. Brains were 
transferred into DMEM/F12 media with 10% FBS and triturated until homogenous. Cells were plated and 
left 2-3 weeks at 37°C with 5% CO2. Astrocytes were removed from the plate with a 1:3 dilution of 0.25% 
Trypsin in HBSS in DMEM/F12 media. Plates were washed and microglia removed with 0.25% Trypsin in 
PBS. Cells were spun down and resuspended in DMEM/F12 with 10% FBS. Microglia for conditioned 
media collection were plated at a density of 1,000,000 cells / well in 6 well plates. After 24 hours, cells 
were washed and switched to serum free media. Media was collected and replaced every 48 hours for 4 
days. Cells used for imaging were plated at 300,000 cells / well in ibiTreated 8-well chamber slides (ibidi 
80826).  
 
Live cell imaging 
After 24 hours, cells were labeled with a 1:1000 concentration of CellTracker (Thermo Fischer C2110) in 
media for 30min at 37°C. Cells were washed and media was replaced. All cells received fresh, serum free 
media except for astrocytes which were treated with microglia conditioned media. After 6 hours, pHrodo 
conjugated synaptosomes, prepared as described above, were added to the media. Cells were imaged at 
37°C at 5% humidity over the course of 16 hours. Six 20x images were acquired across each well at each 
time point. Cells were imaged again at 24 hours and either fixed in 4% PFA for 5min and stored in PBS, or 
washed and media replaced for 16 hours before fixation.  
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Immunocytochemistry and Imaging 
After fixation, cells were washed in PBS and blocked (3% Normal Donkey Serum, 0.2% Triton-X, 0.5% BSA 
in PBS pH7.4) for 1hr at room temperature. Cells were incubated in block with PSD95 (Millipore MAB1596, 
1:1000) at 4°C overnight. Cells were washed and incubated in a 1:1000 concentration of Alexa-conjugated 
secondary antibody in block for 1hr at room temperature. Cells were washed and kept in PBS for imaging. 
One hundred 20x tiled images were acquired for each well. 
 
Cell Imaging Analysis 
For analysis of synaptic uptake in fixed cells, images of each well were stitched together and a threshold 
determined to assess the total area of cells across each well. pHrodo+ signal that localized within cells was 
thresholded and the area quantified. This area was divided by the total cell area. Within each experiment, 
each replicate was normalized to the Trem2+/+ average and reported as percent internalized synaptosome 
volume normalized to Trem2+/+. For experiments assessing uptake of Trem2+/+ vs Trem2-/- synaptosomes, 
replicates were defined as individual mice from which synaptosomes were isolated. For experiments 
assessing uptake of synaptosomes by Trem2+/+ vs Trem2-/- microglia, replicates were defined as individual 
pups from which microglia were cultured.  
 For analysis of degradation of synaptic material, two wells for each replicate were included on 
each plate. One well was fixed after 24hr exposure to synaptosomes (condition A) and the other 
transferred to fresh media and fixed after an additional 16hr (condition B). As described above, images 
were stitched and the total cell area thresholded. pHrodo+ area within regions defined as cells was 
identified and the percent of that area that was also PSD95+ quantified. The ratio of this value in condition 
B to condition A was determined for each replicate. Any values greater than 1 were excluded from the 
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analysis. This ratio was then subtracted from 1 and multiplied by 100 to yield the reported value of 
percent degraded PSD95.  
 For live cell imaging experiments, the cell threshold was determined across the imaged regions 
and the pHrodo+ area within cells quantified as described above. Within each experiment, each replicate 
at each time point was normalized to the average percent internalized synaptosome volume quantified in 
unconditioned media conditions after 24 hours of incubation. In these experiments, each replicate 
represents an individual mouse from which microglia were cultured and conditioned media was collected. 
 
Statistics 
Statistical analyses were performed using GraphPad Prism. mEPSC frequency and amplitude were 
analyzed using a two-sample Kolmogorov-Smirnov test. Two-sided, unpaired t-tests were used to 
determine statistical differences in all other cases where two groups were compared.  2-way ANOVAs 
with Tukey posthoc tests were used in contexts in which multiple variables were being simultaneously 
compared. Column statistics were performed to identify outliers and these samples were excluded. 
Except as specifically defined for electrophysiological experiments, live cell imaging and analysis of 
microglial morphology and synaptic uptake, each n represents a biological replicate. In box and whisker 
plots, the box represents the 25th - 75th interquartile range and whiskers represent the min and max 
values. Bar graphs represent the mean and error bars denote the SEM. Mice from three separate cohorts 
were included for each group.  
 
RESULTS  
TREM2 deficient mice exhibit changes in synaptic connections following development 
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To determine whether TREM2 has a biologically meaningful role in shaping brain development, we 
assessed whether Trem2-/- mice exhibited alterations in synaptic transmission at 1-1.5-months of age, a 
time point just after most developmental synapse formation and elimination is normally complete 
(Thion & Garel, 2017). Whole cell voltage clamp recordings of CA1 neurons in hippocampal slices 
prepared from Trem2+/+ and Trem2-/- mice (Fig 1A) revealed a significant and substantial reduction in 
mEPSC frequency with loss of TREM2 (Fig 1B). This supports a TREM2-dependent role for microglia in 
regulating appropriate synaptic connections in the hippocampus.  
Microglia have recently been shown to be required for postsynaptic maturation of CA1 neurons 
through a CX3CR1-dependent mechanism (Basilico et al., 2019). To determine whether there were also 
TREM2-dependent changes in postsynaptic function in this region, we evaluated mEPSC amplitude (Fig 
1C), mEPSC rise and decay time and AMPA:NMDA ratios, but found no significant effect of Trem2 
genotype on these measures of postsynaptic function (data not shown). Thus, TREM2 and CX3CR1 have 
separable roles in mediating microglia-dependent development in this region. Rather than synaptic 
maturation, the selective decrease in mEPSC frequency observed in Trem2-/- mice suggests that there are 
either fewer synapses onto CA1 neurons or that presynaptic function of these inputs is impaired. 
 
TREM2 expression is broadly required for appropriate regulation of synapse number  
To assess whether the electrophysiological changes observed in TREM2 deficient mice were due to 
changes in synapse number, we quantified the number of synaptophysin+ pre-synaptic elements, 
PSD95+ excitatory postsynaptic elements, and their apposition (Fig 1D), which have previously been 
used to evaluate microglial modulation of synapse number in other contexts (Ippolito & Eroglu, 2010). 
TREM2 deficiency resulted in a significant decrease in the number of presynaptic elements and a strong 
trend toward a reduction in apposed synaptic elements (Fig 1E) in CA1, suggesting that a reduction in 
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synapse number is likely responsible for the TREM2-dependent electrophysiological changes observed. 
While microglia have previously been shown to affect synapses in CA1 (Filipello et al., 2018; 
Paolicelli et al., 2011), we wanted to assess whether TREM2 was also required for establishing 
appropriate synapse number more broadly across the brain. To evaluate this, we quantified synapses 
across several regions of the cortex and hippocampus (Fig 1F). We found that there were significant 
reductions in synaptophysin+ presynaptic elements almost globally across the regions analyzed, and we 
observed a significant reduction in apposed synaptic elements in many of these regions (Table 1). In the 
motor cortex, we also found reductions in postsynaptic elements (Fig 1G). These data demonstrate that 
there are widespread effects of TREM2 deficiency on synaptic development. 
While quantification of synaptophysin and PSD95+ puncta has previously been used to evaluate 
synapse number, it is possible that the changes observed in these measurements could instead 
represent alterations in the composition of synapses themselves. To ensure that our data did not reflect 
a change in abundance or localization of these specific proteins at the synapse, we prepared enriched 
synaptosomal fractions from brains of Trem2+/+ and Trem2-/- mice (Fig S1A). In Western blots on lysates 
prepared from these fractions (Fig 1H), we observed no differences in the levels of synaptophysin (Fig 1I) 
or PSD95 (Fig 1J), indicating that the abundance of these proteins at synapses was unaffected. To ensure 
that our results were not specific to these markers, we also evaluated levels of additional synaptic 
components within synaptosome enriched fractions (Fig S1B) and detected no differences in other 
presynaptic elements, including synapsin (Fig S1C) or postsynaptic elements, including NR2B (Fig S1D) 
and NR2A (Fig S1E). While these synaptosomes were isolated from the whole brain, and therefore we 
cannot exclude the possibility of region-specific differences in synaptic protein distribution, these data 
are suggestive of a requirement for TREM2 in regulation of brain development by controlling 
appropriate synapse number. 
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TREM2 deficiency increases the amount of synaptic material engulfed by each microglial cell 
There could be several possibilities for how microglia regulate synapse number. Microglia are known to 
alter both production and elimination of neurons during development (Freeman, 2006), but we  
detected no differences in neuronal number across any brain region examined (data not shown). 
Microglia can also control synapse number by directly engaging in engulfment of supernumerary 
synapses (Schafer et al., 2012). To evaluate whether TREM2 expression affected engulfment of synaptic 
material in microglia, we quantified the volume of PSD95+ elements internalized within Trem2+/+ and 
Trem2-/- microglia (Fig 2A). TREM2 deficient microglia contained significantly more engulfed PSD95 in 
layer V of the motor cortex (Fig 2B), where we had previously observed decreases in postsynaptic 
elements. In CA1 (Fig 2C) and other brain regions where postsynaptic elements were unaffected by 
Trem2 genotype, we observed no significant differences in PSD95 engulfment (Table 2), demonstrating a 
correlation between increased synaptic engulfment by microglia and reduced synapse number.  
The increased presence of synaptic material within Trem2-/- microglia could be due to intrinsic 
differences in the ability of TREM2 deficient microglia to engulf synapses. To evaluate this possibility, we 
cultured primary microglia from Trem2+/+ or Trem2-/- littermates and exposed these cells to pHrodo 
conjugated synaptosomes isolated from the brains of Trem2+/+ mice (Fig S2A). After incubating cells with 
synaptosomes for 24 hours, cells were fixed and the volume of engulfed synaptosomes quantified and 
normalized to total cell volume. We observed no differences in synaptosome uptake between Trem2+/+ 
and Trem2-/- microglia (Fig S2B). In this system, degradation of engulfed synaptic material was also 
unaffected by Trem2 genotype (Fig S2C).  
Since we did not detect any intrinsic differences in the ability of Trem2+/+ and Trem2-/- microglia to 
engulf or degrade synaptic elements in vitro, we evaluated whether the increased synaptic engulfment 
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by Trem2-/- microglia in vivo might instead be due to differences in the properties of synapses present in 
the brains of Trem2-/- mice. To determine whether these synapses might be a better substrate for 
microglial engulfment, we evaluated whether Trem2-/- mice had increased levels of complement 
components, which are known to serve as tags to target microglial synapse elimination (Stevens et al., 
2007). There were no significant changes in gene expression of complement components in the cortex 
(Fig S2D) or hippocampus (data not shown), though there was a trend toward an increase in C1q protein 
expression in cortical lysates (Fig S2E). We were unable to detect C1q or C3 in synaptosome enriched 
protein fractions to determine whether there were also genotype-dependent alterations in association 
of complement proteins with synapses. Cultured microglia showed no preference for uptake of 
synaptosomes isolated from the brains of Trem2-/- mice relative to Trem2+/+ controls (Fig S2E). Thus, we 
were unable to identify any differences in the intrinsic capacity of microglia to engulf more synapses, nor 
were synapses from Trem2-/- mice clearly a better substrate for microglial engulfment in the assays 
performed. 
 
TREM2 is required to establish appropriate microglial number and regulates microglial distribution 
While the intrinsic capacity of Trem2-/- microglia to engulf synapses was not significantly altered, perhaps 
there were other changes in the phenotype of Trem2-/- microglia that could influence synaptic uptake in 
vivo. Upon examining microglia in the brains of TREM2 deficient mice, striking differences in microglial 
morphology were apparent (Fig 3A). We analyzed microglial size and structure using Sholl analysis (Fig 
3B) as previously described (Norris et al., 2014) and used a hull and circle algorithm to assess features of 
the size and distribution of the territory occupied by each cell (Fig 3B). Sholl analysis revealed an increase 
in the total number of intersecting branches across concentric radii established around the cell body (Fig 
3C). This was not due to changes in the extent of branching of these cells, as the number of primary 
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branches extending from the cell body (Fig 3D) and the mean number of branches intersecting each 
concentric radius (Fig 3E) were unchanged. Rather, increased total branch number was driven by an 
increase in the size of Trem2-/- microglia as measured by the distance from the center of the cell body to 
the edge of the longest process (Fig 3F). We further assessed whether there were changes in the 
distribution or polarity of the branches, but found no differences in the circularity of the convex hull 
circumscribing the microglial processes (Fig 3G), the ratio of the minimum and maximum radii drawn 
through the convex hull (Fig 3H), or the ratio of the area of the convex hull to the bounding circle (Fig 3I) 
with Trem2 genotype. However, the average area of the convex hull was significantly increased in Trem2-
/- microglia (Fig 3J), further supporting an increase in cell size and consequently the area occupied by 
each cell. Similar results were observed across many brain regions (Table 3). This demonstrates that 
TREM2 is dispensable for determining the appropriate morphological features of microglia, but is 
required for determining the appropriate size of these cells. 
We wanted to determine whether differences in the properties of individual microglia observed 
in Trem2-/- mice would also affect the distribution of these cells across the brain. To address this, we 
identified cell bodies of microglia across several brain regions and used these as seeds to generate 
Voronnoi tessellations, which define territories in which each point is closer to the cell body of a given 
microglia than it is to any other microglial cell body (Fig 3K). Using this method, we found that the 
average territory occupied by each microglia was significantly larger in Trem2-/- mice across the cortex, 
hippocampus (Fig 3L) and other brain regions (Fig S3A). This method of analysis has also previously been 
used to assess the regularity of microglial distribution (Bouvier et al., 2016). Interestingly, we found that 
in addition to occupying larger territories, Trem2-/- microglia had more variability in territory size (Fig 3M, 
S3B). This suggests that TREM2 is not only required for determining microglial size, but also to ensure 
regular tiling of these cells. How microglial tiling is controlled, up to now, is unknown, but our data 
clearly implicate TREM2 in this process. 
20 
Because TREM2 deficient microglia occupy larger territories, unless these territories overlap and 
violate normal principles of microglial tiling, there must be fewer microglia in the brains of Trem2-/- mice. 
Indeed, when we quantified the number of microglia (Fig S3C) across the cortex, hippocampus (Fig 3N), 
and other brain regions (Fig S3D), there was a significant effect of genotype by 2-way ANOVA, reflective 
of a nearly universal reduction in the density of microglia. One exception was in the posterior parietal 
cortex, in which we also failed to observe changes in microglial size (Table 3) or significant differences in 
territory mean (Fig 3L) or variance (Fig 3M), suggesting that these features may be coordinately 
regulated. TREM2 has previously been shown to interact with CSF1R signaling (Wang et al., 2015), and 
signaling through the CSF1 receptor on microglia is required for their survival (Elmore et al., 2014). We 
tested whether changes in CSF1R signaling could be responsible for the reduction in microglial number 
observed in Trem2-/- mice. While gene expression of CSF1R and its ligands CSF1 and IL34 (Wang et al., 
2012) were unchanged in cortical and hippocampal lysates (data not shown), we did detect a trend 
toward a decrease in CSF1 (Fig S3E) and a significant decrease in IL34 (Fig S3F) protein levels by ELISA in 
cortical lysates from Trem2-/- mice. This indicates that TREM2 does interact with the CSF1R signaling 
pathway, which likely contributes to the reduction in microglia number in Trem2-/- mice, and may also 
drive changes in microglial size and distribution.     
 
Uptake of synaptic elements by microglia as a population is reduced in Trem2-/- mice 
As we previously showed, individual microglia engulf more synapses in TREM2 deficient mice across 
several brain regions (Fig 3O). However, our data also show that TREM2 deficiency reduces the number 
of total microglia in these areas. To investigate whether microglia as a population contain more 
synapses, we normalized the number of engulfed PSD95+ synaptic elements within microglia to the 
differences in microglial density between genotypes. The ratio of PSD95+ elements in microglia in Trem2-
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/- mice relative to Trem2+/+ mice was significantly below 1 for almost all regions examined (Fig 3P), 
indicating that overall synaptic engulfment by microglia is reduced. This also suggests that individual 
microglia may take up more synapses in Trem2-/- mice simply because there are more synapses available 
for engulfment. 
 
TREM2 is required to limit synaptic uptake by astrocytes  
Based on the finding that Trem2-/- microglia as a population engulf fewer synapses, we would expect that 
synaptic number would be increased in Trem2-/- mice. But we clearly showed that synaptic numbers are 
reduced, to the point of having substantial effects on electrophysiology in Trem2-/- mice. If this isn’t 
mediated by enhanced engulfment of synapses by microglia, then microglia must regulate synapse 
number through another mechanism. It has recently been shown that in contexts of injury or 
neurodegeneration, microglia potently influence the phenotype of astrocytes (Liddelow et al., 2017). 
Like microglia, astrocytes also engage in synaptic engulfment during development (Chung, Allen, & 
Eroglu, 2015). However, it has never been evaluated whether microglia can influence developmental 
synapse elimination by astrocytes.  
To address whether TREM2 could influence synapse number by mediating microglial influence 
over astrocytic synaptic pruning, we tested whether astrocytes in Trem2-/- mice engulfed more synapses 
by assessing the volume of PSD95 internalized within Aldhl1+ astrocytes in the brains of Trem2+/+ and 
Trem2-/- mice (Fig 4A). Indeed, we found that there was an increase in internalized synaptic elements 
within astrocytes in Trem2-/- mice in layer V of the motor cortex (Fig 4B), CA1 (Fig 4C) and many other 
brain regions (Table 4). There was no change in astrocyte volume across these regions (Fig S4C). 
Together, this demonstrates that TREM2 deficiency does increase synaptic engulfment by astrocytes and 
establishes a novel role for microglia in instructing astrocyte synapse engulfment during brain 
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development. In support of a role for microglia in modulation of astrocytic synaptic uptake, we found 
that in vitro, microglia conditioned media could significantly inhibit synaptosome uptake by astrocytes 
(Fig S4A, B). Conditioned media from Trem2-/- also inhibited uptake of synaptosomes by astrocytes, 
except at 24 hours, when there was no significant difference between synaptic uptake by astrocytes 
exposed to unconditioned media or Trem2-/- conditioned media. This may indicate that Trem2-/- microglia 
fail to produce some of the factors produced by microglia that normally serve to limit synaptic uptake by 
astrocytes. However, only brain regions in which microglial number was significantly reduced by TREM2 
deficiency showed increased synaptic engulfment by astrocytes (Table 4), suggesting that a decrease in 
the population of microglia is likely a primary contributor to enhanced astrocytic engulfment in Trem2-/- 
mice. 
 
Increased engulfment of synapses in astrocytes in TREM2 deficient mice contributes to a reduction in 
synapse number 
The increase in synapse engulfment within astrocytes could explain the reduction in synapse number 
observed in TREM2 deficient mice. However, because synaptic uptake is reduced in Trem2-/- microglia, to 
fully explain the synaptic loss, astrocytes in Trem2-/- mice must increase synaptic uptake by more than 
Trem2-/- microglia reduce it. To determine whether microglia or astrocytes engulfed more synapses, we 
first compared the percent volume of each glial subtype that was comprised of internalized PSD95. In 
layer V of the motor cortex, per volume, microglia contain more synaptic material than astrocytes (Fig 
4D). However, astrocytes occupy substantially more volume within the brain (Fig 4E). Thus, when the 
total internalized PSD95+ volume within glia is quantified, the decrease in synaptic uptake by microglia is 
far outweighed by the increase in synaptic engulfment by astrocytes (Fig 4F). While we have not fully 
excluded other possible contributions to the decrease in synapse number, such as alterations in synapse 
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formation (Fig S4D) (Ullian et al., 2001), enhanced engulfment of synaptic elements by glia clearly 
contributes to the synaptic reductions observed in TREM2 deficient mice. In contrast to our expectation 
that these differences would be driven directly through TREM2’s effect on interactions between 
microglia and synapses, these changes are instead driven by an impaired ability of microglia to 
appropriately limit astrocytic synaptic engulfment. 
 
Many TREM2-dependent developmental changes observed at 1 month of age are normalized later in 
adulthood 
To investigate whether the changes we observed at 1 month of age persist throughout the lifetime of 
the animal, we quantified synapse number in 4-month-old Trem2+/+ and Trem2-/- mice (Fig 5A). At this 
age, there were no longer significant differences in synaptic elements in layer V of the motor cortex (Fig 
5B) or in CA1 (Fig 5C). Microglial engulfment of PSD95 at 4 months of age (Fig 5D) was reduced in layer V 
of the motor cortex in TREM2 deficient mice (Fig 5E, Table 5) with no change in CA1 (Fig 5F). The changes 
we observed previously in microglial size, as measured by the area of the convex hull (Fig 5G) and the 
length of the longest process (Fig 5H) were also normalized. There were also no significant differences 
with Trem2 genotype in microglial territory size (Fig 5I) or variance (Fig 5J). Correspondingly, the density 
of microglia was no longer significantly altered at this age (Fig 5K). Because we posited that at 1 month 
of age, reductions in microglial number may have been due to reduced CSF1R signaling, we investigated 
whether expression of CSF1R and its ligands were also normalized by 4 months of age. Similar to what 
we observed at 1 month, there was no genotype-dependent difference in CSF1R gene expression (data 
not shown), and there was still a significant reduction in protein levels of the ligand IL34 in Trem2-/- mice 
(Fig S5A). CSF1 protein levels did normalize at this age (Fig S5A), but it remains to be determined 
whether this is responsible for the recovery in microglial density or whether other cues may also 
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mediate microglial survival and abundance later in adulthood. 
In 1-month-old Trem2-/- mice, enhanced synaptic uptake by astrocytes accounted for the increase 
in synaptic loss we observed, so we wanted to determine whether this was similarly normalized by 4 
months of age. Consistent with the return to normal synapse number, uptake of PSD95 in astrocytes (Fig 
5L) was no longer significantly altered in Trem2-/- mice compared to Trem2+/+ mice in motor CX layer V 
(Fig 5M, Table 7) or CA1 (Fig 5N, Table 7). However, unlike at 1 month of age, there was a significant 
decrease in several genes associated with astrocyte-driven synapse formation and maturation in cortical 
lysates from 4-month-old TREM2 deficient mice (Fig S5B), suggesting that there may still be microglial-
driven changes in how astrocytes influence new synapse formation or synaptic function later in 
adulthood. 
   
Developmental TREM2-dependent synaptic reductions can be reinitiated in adulthood 
By 4 months of age, many aspects of microglial and astrocytic phenotypes that were altered with TREM2 
deficiency earlier in development were apparently normalized and synapse number was no longer 
significantly altered, suggesting that there are likely additional mechanisms that control synaptic uptake 
by astrocytes later in adulthood that are independent of TREM2. However, glial developmental functions 
have been shown to be aberrantly reinitiated in adulthood (Hong et al., 2016) in response to injury, 
infection or metabolic challenge. To test whether the developmental function of TREM2 in regulating 
appropriate synapse number could be reinitiated in adulthood in these contexts, we administered a high 
fat diet. Trem2+/+ and Trem2-/- mice were fed a standard diet until they reached 1 month of age, at which 
time littermates were separated and either maintained on a standard diet or fed a high fat diet until they 
were sacrificed at 4 months. We then evaluated whether there was an interaction between TREM2 
deficiency and high fat diet in the number of synaptic elements present in different brain regions. In 
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layer V of the motor cortex, there was no significant interaction between genotype and diet in the 
number of synaptophysin+ (Fig 6A) or PSD95+ (Fig 6B) elements alone. But, we did find that diet had a 
significant effect only in Trem2-/- mice on measures of apposed synaptic elements (Fig 6C), which reflect 
the total possible number of functional synapses (Ippolito & Eroglu, 2010), and in the proportion of 
synaptophysin+ elements which were apposed to PSD95 (Fig 6D) as well as the proportion of PSD95+ 
elements that were apposed to synaptophysin (Fig 6E). Similar effects were also observed in other brain 
regions, including layers II and III of the motor cortex (Fig 6F-J) and CA1 (Fig 6K-O). Together, the 
reduction in synapses in Trem2-/- mice with high fat diet administration suggests that TREM2 is required 
on microglia to regulate appropriate synapse number in later adulthood following metabolic challenge, 
as was observed during development. In this context, however, TREM2 also seems to be required to 
modulate the specificity of synapse elimination, as in some regions such as layer V of the motor cortex, 
there were no changes in individual synaptic elements, but those remaining in Trem2-/- mice were less 
likely to be engaged in synaptic contacts. This demonstrates that TREM2 can play a role in regulation of 
synapse number in adulthood following high fat diet administration and may also be required in this 
context for selective maintenance of functional synapses.  
 
DISCUSSION 
Synaptic changes in TREM2 deficient mice 
In this study, we demonstrate that TREM2 is critical for appropriate synaptic refinement during 
neurodevelopment. Microglia have previously been implicated in this process in the lateral geniculate 
nucleus (Schafer et al., 2012) and the CA1 region of the hippocampus (Filipello et al., 2018; Paolicelli et 
al., 2011). Our study extends these findings by demonstrating that microglia affect development very 
broadly across the nervous system, as TREM2 deficiency led to changes in synapse number in several 
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regions of the cortex and hippocampus. We report a robust reduction in mEPSC frequency in CA1 
neurons in Trem2-/- mice at 1-1.5 month of age, due to a reduction in synapse number. This finding is 
distinct from that reported by Filipello and colleagues, who reported increased mEPSC frequency in P18-
P20 mice with TREM2 deficiency, consistent with an increase in synaptic protein levels (Filipello et al., 
2018). The basis for these discordant outcomes is unclear. The differences between our studies could be 
due to dynamic changes in how TREM2 regulates microglial-dependent synapse elimination over the 
course of development, but in control experiments (not shown) we also found reductions in mEPSC 
frequency in CA1 neurons at P20, consistent with what we observed at 1 – 1.5 months of age. Another 
possibility is a difference in the Trem2-/- model we used. Our model has recently been shown to display 
an increase in another gene within the Trem locus, Treml1 (Kang et al., 2018), while Filipello and 
colleagues’ knockout models do not (Filipello et al., 2018). However, we also confirmed our 
electrophysiology results in mice with a knock-in of the Trem2 R47H variant which exhibits substantial 
loss of Trem2 gene expression in mice due to the introduction of a cryptic splice site (Xiang et al., 2018), 
but does not alter expression of Treml1 or other genes in the Trem locus (Cheng-Hathaway et al., 2018). 
Again, we observed a decrease in mEPSCs in these knock-in mice (data not shown), demonstrating that 
the differences aren’t model specific. Because we found that the TREM2-dependent synaptic loss in our 
model could be modulated by diet, it is possible that our opposing findings are due to differences in as of 
yet undefined environmental factors.  
TREM2 deficiency affected the number of synapses and glial engulfment of synaptic elements 
across several brain regions. However, we found that while synaptophysin was reduced across most 
regions, PSD95 was specifically affected in the motor cortex. This suggests that microglia have different 
roles in directing targeting of particular synaptic elements depending on the circuit. The regional 
differences we observed in synaptic changes in Trem2-/- mice could be due to regional diversity of 
microglia (Grabert et al., 2016). Perhaps the TREM2-dependent microglial signals that modulate synapse 
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elimination are differentially expressed or astrocytes in different brain regions may be differentially 
responsive to these cues. These factors may also change over time, governing when different circuits 
undergo heightened periods of synaptic refinement.   
The normalization of appropriate synapse number by 4 months of age in TREM2 deficient mice 
suggests that there are additional mechanisms which normally serve to limit inappropriate elimination of 
synapses by glia later in adulthood. However, we found that TREM2 can again influence synapse number 
in 4-month-old mice following high fat diet administration. While high fat diet administraiton was used 
simply as a means of altering the brain inflammatory environment in this study, these findings do 
indicate an important interaction between TREM2 and diet on CNS function and it would be of interest 
to determine whether TREM2 could be related to metabolic syndrome in future studies. It is not yet 
clear whether this is driven by reinitiation of the same mechanisms by which TREM2 influences 
developmental synaptic refinement. However, TREM2 is also known to affect the phenotype of 
astrocytes in AD mouse models (Jay et al., 2017; Jay et al., 2015). It will be of great interest to determine 
whether influencing the phenotype of astrocytes is a common function of TREM2 across metabolic 
challenge, injury and disease states, and whether these changes result in astrocyte-driven synaptic 
alterations in these other contexts. If so, regulation of astrocytic synaptic engulfment may be a key 
mechanism for how TREM2 broadly influences NDD pathology. 
 
Microglia instruct synaptic elimination by astrocytes 
One of the key findings of this study is that microglia interact with astrocytes to coordinate their 
shared function of synaptic refinement during development. There are examples of microglia influencing 
the phenotype of astrocytes in disease or injury (Liddelow et al., 2017), and our study extends these 
findings by identifying a role for communication between these cell types in normal brain function. 
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Specifically, we found that microglia can limit astrocyte uptake of synapses. This effect was partially 
dependent on TREM2 expression, resulting in increased astrocytic engulfment of synaptic elements in 1-
month-old Trem2-/- mice. The signals that mediate this effect seem to be released from microglia, as 
microglia conditioned media was able to effectively limit astrocytic synaptic uptake. It is not entirely 
clear what these signals might be. Through release of TNFa, IL1 and C1q, microglia have previously been 
shown to reduce astrocytic gene expression of the receptors MerTK and Megf10 (Liddelow et al., 2017), 
which are required for their engulfment of synapses during neurodevelopment (Chung et al., 2015). 
Thus, release of these factors by microglia could be responsible for decreasing astrocytic synaptic 
engulfment. Other possible candidates for microglial-derived signals include TGFβ, which is known to 
reduce astrocytosis (Liddelow et al., 2017) and has also been shown to limit synapse loss following 
astrocyte activation (Diniz et al., 2017). Microglial derived FGF has been shown to be important for 
limiting astrocyte activation (Kang et al., 2014) though its specific effect on synaptic uptake by astrocytes 
has not yet been evaluated. In addition to the release of soluble factors, microglia have also been shown 
to communicate with other brain cell types through release of extracellular vesicles (Delpech et al., 2019; 
Paolicelli et al., 2019), which could also mediate microglial signaling to astrocytes in this context. 
Identifying the signals used by microglia to alter astrocyte synaptic uptake promises to provide a means 
to potently regulate astrocytic elimination of synapses which would be of great interest in pathological 
contexts in which aberrant glial function drives synaptic loss.  
 
Changes in microglial phenotype in TREM2 deficient mice 
In Trem2-/- mice, microglia contained more engulfed synaptic elements in several brain regions. Because 
TREM2 has been shown to be required for phagocytosis of a variety of substrates, including apoptotic 
cells (Hsieh et al., 2009; Yeh et al., 2016) this could have been due to intrinsic differences in the ability of 
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Trem2-/- microglia to take up or degrade synapses. However, Trem2+/+ and Trem2-/- microglia displayed no 
differences in synaptic uptake or degradation in vitro, though because microglia undergo extensive 
transcriptional changes when removed from the brain microenvironment (Bohlen et al., 2017), we 
cannot exclude that in vivo these cells have a different capacity for synaptic uptake or degradation. 
Alternatively, we thought that synapses themselves may be different in Trem2-/- mice in some way that 
made them a better substrate for engulfment. We did not detect a preference for uptake of Trem2-/- 
synaptosomes by microglia, nor did we detect genotype-dependent changes in expression of 
complement components. However, it is possible that there are changes in protective signals such as 
SIRPα which has recently been shown to inhibit microglial uptake of synapses (Lehrman et al., 2018) or 
yet to be identified alternative cues that direct microglial synapse elimination. However, in our study, we 
posit that the major contributor to an increase in synaptic elements within microglia is simply because 
these cells are larger and cover a larger territory, thus having more possible synapses available for 
uptake. 
 These TREM2-dependent changes in microglial size and distribution are important because very 
little is known about what normally governs these fundamental processes during microglial development 
and homeostasis. It is well known that the number of microglia in the brain is tightly regulated (Askew et 
al., 2017; Fuger et al., 2017), in part though CSF1R signaling. CSF1R antagonists effectively eliminate 
microglia from the brain (Elmore et al., 2014) and zebrafish and patients with CSF1R mutations display 
reduced microglial density (Oosterhof et al., 2018). TREM2 deficiency did result in reduced levels of the 
CSF1R ligand IL34, which may be responsible for the reduction in microglial number in Trem2-/- mice. It 
remains to be understood how TREM2 influences IL34 protein levels, as it is thought to be produced 
exclusively by neurons. Because TREM2 is known to be important for microglial proliferation (Otero et 
al., 2012; Zheng et al., 2017) and chemotaxis (Mazaheri et al., 2017) in response to damage or disease, it 
may also be that a failure in these processes contributes to the reduction in microglia observed in brain 
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development. 
 TREM2 is also important for establishing appropriate microglial size and tiling. In Trem2-/- mice, 
microglial structure was unchanged, but the cells were larger. This demonstrates that microglial size and 
structure are governed by separable mechanisms. In addition to regulating the size of the territories that 
microglia occupy, TREM2 was also required for establishing the regularity of microglial territories. This 
regularity of tiling is integral for microglia to be able to efficiently sample the brain microenvironment, 
and the identification that this requires TREM2 provides the first insight into pathways that govern this 
process.  
Implications for TREM2 function in neurodegenerative diseases 
Microglial number, size and distribution are also features that change dramatically and rapidly 
following injury or disease. Just as TREM2 was required to establish the appropriate number of microglia 
during development, it has also been shown to be required for expansion of the microglial population 
following brain injury (Kawabori et al., 2015; Poliani et al., 2015; Saber et al., 2017; Sieber et al., 2013) 
and for changes in microglial distribution in AD mouse models (Jay et al., 2015; Ulrich et al., 2014; Wang 
et al., 2015; Yuan et al., 2016). This suggests that TREM2 may work through a common mechanism to 
establish microglial number and distribution in the healthy brain and appropriately recalibrate these 
features in disease. Future studies will be required to determine whether TREM2 is also required to 
protect against disease-associated synaptic loss through similar mechanisms to those identified here. 
Studying the functional role of TREM2 on microglia provided novel insights into critical functions 
of these cells in the normal brain. We found that microglia play a widespread role in neurodevelopment, 
and showed that they can limit synaptic uptake by astrocytes, thus tuning the appropriate level of 
developmental synapse elimination. Microglia continue to integrate a wide variety of environmental 
cues, including diet and disease-related factors and communicate these conditions to astrocytes in such 
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a way that meaningfully changes their phenotype and regional synapse number in adulthood. 
Uncovering these important functions of microglia in brain homeostasis also suggest novel roles for 
microglia which could importantly modulate brain injury and disease.  
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TABLES 
 Table 1: Regional changes in synaptic elements in 1-month-old Trem2-/- mice 
 
Data are presented as Trem2+/+ (WT) mean ± SEM vs Trem2-/- (KO) mean ± SEM, t(degrees of freedom) = t value, p = 
p value. Boxes are shaded in conditions where there was a significant (p<0.05, dark gray) or a trend toward 
a significant (p<0.10, light gray) reduction in synaptic elements in Trem2-/- mice relative to Trem2+/+ mice. 
  
 Synaptophysin+ Puncta PSD95+ Puncta Apposed  Synaptic Elements 
Motor CX Layer V ↓ (WT 0.28 ±0.02 vs KO 0.14 ± 
0.02 t(7) = 4.31, p = 0.0035) 
↓(WT 0.33 ±0.02 vs KO 0.22 ± 
0.04 t(7) = 2.15, p = 0.0686) 
↓ (WT 0.18 ±0.01 vs KO 0.08 ± 
0.02 t(7) = 3.90, p = 0.0059) 
Somatosensory 
CX Layer V 
↓ (WT 0.27 ±0.01 vs KO 0.17 ± 
0.05 t(7) = 1.89, p = 0.100) 
↔ (WT 0.26 ±0.04 vs KO 0.24 
± 0.04 t(7) = 0.421, p = 0.686) 
↔ (WT 0.14 ±0.02 vs KO 0.09 ± 
0.03 t(7) = 1.402, p = 0.204) 
Somatosensory 
CX Layers II/III 
↔ (WT 0.22 ±0.01 vs KO 0.17 
± 0.03 t(7) = 1.69, p = 0.135) 
↔ (WT 0.26 ±0.03 vs KO 0.16 
± 0.05 t(7) = 1.70, p = 0.133) 
↔ (WT 0.12 ±0.01 vs KO 0.08 ± 
0.03 t(7) = 1.54, p = 0.168) 
CA1 Stratum 
Radiatum 
↓ (WT 0.33 ±0.01 vs KO 0.22 ± 
0.05 t(7) = 2.40, p = 0.047) 
↔ (WT 0.18 ±0.06 vs KO 0.18 
± 0.10 t(7) = 0.89, p = 0.401) 
↓ (WT 0.16 ±0.02 vs KO 0.08 ± 
0.03 t(7) = 0.2.03, p = 0.089) 
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Table 2: Regional changes in synaptic element uptake by microglia in 1-month-old Trem2-/- mice 
 
Data are presented as Trem2+/+ (WT) mean ± SEM vs Trem2-/- (KO) mean ± SEM, t(degrees of freedom) = t value, 
p = p value. Boxes are shaded in conditions where there was a significant (p<0.05, dark gray) or a trend 
toward a significant (p<0.10, light gray) increase in synaptic elements in Trem2-/- mice relative to Trem2+/+ 
mice. 
  
 Number of Synapses / Microglia 
Number of Synapses / μm3 
microglia 
Percent Volume of 
Synapses in Microglia 
Motor CX Layer V ↑ (WT 27.06 ±3.74 vs KO 38.36 
± 4.67 t(41) = 1.78, p = 0.0829) 
↑(WT 1.92 ±0.23 vs KO 3.42 ± 
0.56 t(42) = 2.14, p = 0.0382) 
↑ (WT 0.28 ±0.02 vs KO 0.60 
± 0.12 t(42) = 2.20, p = 0.0338) 
Motor CX Layers 
II/III 
↑ (WT 24.23 ±2.15 vs KO 42.48 
± 4.91 t(41) = 3.46, p = 0.0013) 
↑ (WT 2.09 ±0.18 vs KO 3.12 ± 
0.32 t(41) = 2.81, p = 0.0077) 
↑ (WT 0.28 ±0.02 vs KO 0.41 
± 0.03 t(41) = 3.79, p = 0.0005) 
Somatosensory 
CX Layer V 
↔ (WT 41.25 ±3.68 vs KO 38.00 
± 3.65 t(41) = 0.62, p = 0.5402) 
↔ (WT 3.32 ±0.30 vs KO 2.90 ± 
0.24 t(41) = 1.03, p = 0.3092) 
↔ (WT 0.40 ±0.03 vs KO 0.36 
± 0.03 t(42) = 1.42, p = 0.1633) 
Somatosensory 
CX Layers II/III 
↑ (WT 37.97 ±3.86 vs KO 48.32 
± 4.08 t(50) = 1.81, p = 0.0756) 
↔ (WT 11.94 ±0.94 vs KO 11.61 
± 0.92 t(50) = 0.25, p = 0.8074) 
↔ (WT 1.22 ±0.09 vs KO 1.10 
± 0.08 t(50) = 0.99, p = 0.3288) 
Posterior Parietal 
CX Layer V 
↓ (WT 7.00 ±2.12 vs KO 3.54 ± 
0.81 t(19) = 1.79, p = 0.0900) 
↔ (WT 3.61 ±1.03 vs KO 2.93 ± 
0.65 t(19) = 0.561, p = 0.5612) 
↔ (WT 0.56 ±0.11 vs KO 0.44 
± 0.08 t(19) = 0.88, p = 0.3914) 
Posterior Parietal 
CX Layers II/III 
↔ (WT 10.20 ±1.88 vs KO 7.80 
± 0.1.35 t(18) = 1.04, p = 0.3140) 
↔ (WT 5.92 ±0.95 vs KO 3.18 ± 
1.10 t(19) = 2.50, p = 0.0218) 
↔ (WT 0.87 ±0.12 vs KO 0.41 
± 0.07 t(19) = 3.11, p = 0.0058) 
CA1 Stratum 
Radiatum 
↔ (WT 34.43 ±7.15 vs KO 52.33 
± 8.18 t(21) = 1.62, p = 0.1211) 
↔ (WT 9.52 ±1.66 vs KO 10.92 
± 1.08 t(21) = 0.62, p = 0.5423) 
↔ (WT 0.92 ±0.14 vs KO 0.97 
± 0.07 t(21) = 0.33, p = 0.7482) 
Subiculum ↔ (WT 14.75 ±5.46 vs KO 19.13 
± 7.44 t(18) = 0.48, p = 0.6337) 
↔ (WT 5.40 ±1.77 vs KO 6.25 ± 
1.88 t(18) = 0.32, p = 0.7529) 
↔ (WT 0.66 ±0.15 vs KO 1.16 
± 0.31 t(18) = 1.60, p = 0.1273) 
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Table 3: Regional changes in microglia size and morphology in 1-month-old Trem2-/- mice 
 
Data are presented as Trem2+/+ (WT) mean ± SEM vs Trem2-/- (KO) mean ± SEM, t(degrees of freedom) = t value, p = p value. Boxes are shaded in 
conditions where there was a significant increase (p<0.05, dark green), a significant decrease (p<0.05, dark pink) or a trend toward a significant 
decrease (p<0.05, light pink) in the features of microglia listed above in Trem2-/- mice relative to Trem2+/+ mice. 
  
 Convex Hull Area Total Intersections Mean Intersections Length of Longest Process 
Motor CX Layer 
V 
↑ (WT 213500 ±17660 vs KO 321600 ± 
28970 t(37) = 3.37, p = 0.0018) 
↑ (WT 89.5 ±6.92 vs KO 115.6 ± 
8.86 t(39) = 2.657, p = 0.0114) 
↔ (WT 12.02 ±0.68 vs KO 13.49 
± 0.59 t(38) = 1.52, p = 0.1378) 
↑ (WT 38.11 ±1.72 vs KO 47.78 ± 
2.78 t(38) = 3.13, p = 0.0033) 
Motor CX 
Layers II/III 
↔ (WT 235400 ±17750 vs KO 236800 
± 19270 t(39) = 0.05, p = 0.9576) 
↔ (WT 69.05 ±6.49 vs KO 63.26 ± 
5.31 t(39) = 0.67, p = 0.5028) 
↔  (WT 9.86 ±0.73 vs KO 8.76 ± 
0.53 t(39) = 1.19, p = 0.2428) 
↔ (WT 38.24 ±1.89 vs KO 41.59 ± 
2.00 t(39) = 1.23, p = 0.2278) 
Motor CX 
Average 
↑ (WT 224200 ±12490 vs KO 275600 ± 
18120 t(78) = 2.41, p = 0.0185) 
↔ (WT 78.02 ±4.88 vs KO 87.20 ± 
6.63 t(80) = 1.14, p = 0.2571) 
↔ (WT 10.99 ±0.52 vs KO 10.92 
± 0.56 t(79) = 0.09, p = 0.9310) 
↑ (WT 38.17 ±1.25 vs KO 44.42 ± 
1.73 t790) = 3.01, p = 0.0035) 
Posterior 
Parietal CX 
Layer V 
↓ (WT 177100 ±11590 vs KO 145900 ± 
6908 t(21) = 2.44, p = 0.0238) 
↓ (WT 58.10 ±3.35 vs KO 42.31 ± 
2.82 t(21) = 3.63, p = 0.0016) 
↓ (WT 10.01 ±0.89 vs KO 8.20 ± 
0.57 t(21) = 1.78, p = 0.0889) 
↔ (WT 43.01 ±2.23 vs KO 47.35 ± 
3.05 t(21) = 1.17, p = 0.2538) 
Posterior 
Parietal CX 
Layers II/III 
↔ (WT 172400 ±10930 vs KO 184700 
± 12480 t(19) = 0.75, p = 0.4647) 
↔ (WT 51.09 ±2.85 vs KO 53.50 ± 
2.80 t(19) = 0.60, p = 0.5552) 
↔ (WT 9.10 ±0.66 vs KO 9.97 ± 
0.62 t(19) = 0.95, p = 0.3558) 
↔ (WT 32.86 ±1.59 vs KO 32.37 ± 
1.76 t(19) = 0.21, p = 0.8380) 
Posterior 
Parietal CX 
Average 
↔ (WT 174600 ±7767 vs KO 162800 ± 
7699 t(42) = 1.09, p = 0.2840) 
↓ (WT 54.43 ±2.27 vs KO 47.17 ± 
2.29 t(42) = 2.25, p = 0.0301) 
↔ (WT 9.54 ±0.55 vs KO 8.97 ± 
0.45 t(42) = 0.81, p = 0.4220) 
↔ (WT 33.26 ±1.40 vs KO 31.90 ± 
0.91 t(42) = 0.83, p = 0.4117) 
CA1 Stratum 
Radiatum 
↑ (WT 219100 ±14970 vs KO 298300 ± 
27710 t(21) = 2.74, p = 0.0122) 
↑ (WT 68.64 ±4.02 vs KO 97.44 ± 
10.18 t(21) = 3.03, p = 0.0064) 
↑ (WT 9.41 ±0.47 vs KO 11.45 ± 
0.81 t(21) = 2.34, p = 0.0291) 
↔ (WT 43.01 ±2.23 vs KO 47.35 ± 
3.05 t(21) = 1.17, p = 0.2538) 
  
 
Table 4: Regional changes in synaptic element uptake by astrocytes in 1-month-old Trem2-/- mice 
 
 
 
 
 
 
 
 
 
 
Data are presented as Trem2+/+ (WT) mean ± SEM vs Trem2-/- (KO) mean ± SEM, t(degrees of freedom) = t value, 
p = p value. Boxes are shaded in conditions where there was a significant (p<0.05, dark gray) increase in 
synaptic elements in astrocytes in Trem2-/- mice relative to Trem2+/+ mice. 
 
  
 Number of Synapses /  
μm3 Astrocyte 
Percent Volume of 
Synapses in Astrocytes 
Motor CX Layer V ↑ (WT 6.39 ±0.78 vs KO 9.22 ± 
0.69 t(29) = 2.70, p = 0.0114) 
↑ (WT 0.78 ±0.08 vs KO 1.13 
± 0.13 t(29) = 2.43, p = 0.0214) 
Motor CX Layers 
II/III 
↔ (WT 12.91 ±1.81 vs KO 
16.86 ± 2.51 t(13) = 1.24, p = 
0.2365) 
↔ (WT 1.87 ±0.31 vs KO 2.30 
± 0.41 t(13) = 0.81, p = 0.4338) 
Somatosensory 
CX Layer V 
↑ (WT 9.11 ±0.97 vs KO 22.44 ± 
3.60 t(11) = 3.32, p = 0.0068) 
↑ (WT 1.26 ±0.15 vs KO 2.90 
± 0.50 t(11) = 2.95, p = 0.0132) 
Somatosensory 
CX Layers II/III 
↔ (WT 19.06 ±5.55 vs KO 
17.50 ± 1.86 t(13) = 0.28, p = 
0.7819) 
↔ (WT 2.69 ±0.82 vs KO 2.15 
± 0.24 t(13) = 0.67, p = 0.5131) 
Posterior Parietal 
CX Layer V 
↔ (WT 15.44 ±1.65 vs KO 
25.29 ± 5.52 t(5) = 1.96, p = 
0.1069) 
↔ (WT 2.22 ±0.23 vs KO 3.33 
± 0.77 t(5) = 1.60, p = 0.1698) 
Posterior Parietal 
CX Layers II/III 
↔ (WT 13.93 ±0.44 vs KO 
22.47 ± 4.64 t(4) = 1.83, p = 
0.1407) 
↔ (WT 1.44 ±0.27 vs KO 2.08 
± 0.31 t(5) = 1.54, p = 0.1843) 
CA1 Stratum 
Radiatum 
↑ (WT 15.77 ±0.50 vs KO 46.53 
± 8.18 t(6) = 2.82, p = 0.0304) 
↑ (WT 1.67 ±0.30 vs KO 5.45 
± 1.03 t(7) = 3.16, p = 0.0159) 
Subiculum 
↔ (WT 13.51 ±3.35 vs KO 
22.01 ± 3.20 t(8) = 1.77, p = 
0.1142) 
↔ (WT 1.87 ±0.48 vs KO 2.82 
± 0.44 t(8) = 1.42, p = 0.1925) 
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Table 5: Regional changes in synaptic element uptake by microglia in 4-month-old Trem2-/- mice 
 
 
Data are presented as Trem2+/+ (WT) mean ± SEM vs Trem2-/- (KO) mean ± SEM, t(degrees of freedom) = t value, 
p = p value. Boxes are shaded in conditions where there was a significant (p<0.05, dark gray) or a trend 
toward a significant (p<0.10, light gray) decrease in synaptic elements in microglia in Trem2-/- mice 
relative to Trem2+/+ mice. 
  
 Number of Synapses / Microglia 
Number of Synapses 
/ μm3 microglia 
Percent Volume of 
Synapses in Microglia 
Motor CX Layer V 
↔ (WT 118.8 ±9.20 vs KO 
100.9 ± 10.58 t(67) = 1.27, p = 
0.2078) 
↓ (WT 29.71 ±1.64 vs KO 
23.42 ± 1.91 t(68) = 2.51, p = 
0.0146) 
↔ (WT 3.44 ±0.22 vs KO 
3.02 ± 0.29 t(66) = 1.19, p = 
0.2381) 
Motor CX Layer V  
(Excluding Large 
Inclusions) 
↓ (WT 85.98 ±7.02 vs KO 66.97 
± 7.82 t(67) = 1.79, p = 0.0775) 
↓ (WT 21.34 ±1.22 vs KO 
15.48 ± 1.43 t(68) = 3.13, p = 
0.0025) 
↓ (WT 0.97 ±0.06 vs KO 0.71 
± 0.06 t(67) = 3.02, p = 0.0036) 
CA1 Stratum Radiatum ↓ (WT 48.88 ±6.02 vs KO 65.09 
± 5.50 t(54) = 1.97, p = 0.0535) 
↓ (WT 18.15 ±1.82 vs KO 
21.78 ± 1.24 t(54) = 1.71, p = 
0.0931) 
↔ (WT 1.99 ±0.16 vs KO 
1.84 ± 0.11 t(53) = 0.79, p = 
0.4356) 
CA1 Stratum Radiatum 
(Excluding Large 
Inclusions) 
↓ (WT 39.63 ±5.45 vs KO 53.75 
± 4.74 t(54) = 1.96, p = 0.0558) 
↓ (WT 14.51 ±1.66 vs KO 
17.84 ± 1.12 t(54) = 1.72, p = 
0.0909) 
↓ (WT 0.61 ±0.06 vs KO 0.73 
± 0.04 t(54) = 1.72, p = 0.0916) 
  
Table 6: Regional changes in microglia size and morphology in 4-month-old Trem2-/- mice 
 
 
 
Data are presented as Trem2+/+ (WT) mean ± SEM vs Trem2-/- (KO) mean ± SEM, t(degrees of freedom) = t value, p = p value.  
 
 Convex Hull Area Total Intersections Mean Intersections Length of Longest Process 
Motor CX Layer 
V 
↔ (WT 231400 ±14470 vs KO 
262500 ± 19530 t(68) = 1.31, p = 
0.1961) 
↔(WT 74.15 ±4.75 vs KO 
81.47 ± 6.44 t(68) = 0.94, p = 
0.3625) 
↔ (WT 9.74 ±0.48 vs KO 10.11 
± 0.59 t(68) = 0.49, p = 0.6238) 
↔ (WT 42.34 ±1.59 vs KO 45.02 
± 1.95 t(68) = 1.08, p = 0.2860) 
CA1 Stratum 
Radiatum 
↔ (WT 242900 ±15460 vs KO 
232500 ± 11570 t(56) = 0.55, p = 
0.5852) 
↔ (WT 71.19 ±5.77 vs KO 
65.50 ± 3.42 t(56) = 0.88, p = 
0.3804) 
↔ (WT 10.07 ±0.62 vs KO 9.25 
± 0.44 t(56) = 1.10, p = 0.2779) 
↔ (WT 40.41 ±1.44 vs KO 40.25 
± 1.18 t(55) = 0.08, p = 0.9326) 
  
Table 7: Regional changes in synaptic element uptake by astrocytes in 4-month-old  
Trem2-/- mice 
 
 
 
 
 
Data are presented as Trem2+/+ (WT) mean ± SEM vs Trem2-/- (KO) mean ± SEM, t(degrees of freedom) = t value, p = 
p value. Boxes are shaded in conditions where there was a significant (p<0.05, dark gray) increase in 
synaptic elements in Trem2-/- mice relative to Trem2+/+ mice. 
 
 Number of Synapses /  μm
3 
Astrocyte 
Percent Volume of 
Synapses in Astrocytes 
Motor CX Layer 
V 
↔ (WT 13.88 ±1.08 vs KO 14.18 
± 1.46 t(42) = 0.17, p = 0.8693) 
↔ (WT 1.70 ±0.12 vs KO 1.96 
± 0.16 t(42) = 1.28, p = 0.21) 
CA1 Stratum 
Radiatum 
↑ (WT 14.92 ±0.93 vs KO 20.21 ± 
1.54 t(40) = 3.09, p = 0.0037) 
↑ (WT 2.21 ±0.10 vs KO 2.83 ± 
0.19 t(40) = 3.06, p = 0.0040) 
  
FIGURES AND FIGURE LEGENDS 
 
 
Figure 1. TREM2 deficiency results in reduced synapse number (A) Whole cell patch clamp recordings 
of CA1 pyramidal neurons in hippocampal slices from 1-1.5-month-old Trem2+/+ and Trem2-/- mice 
revealed (B) significant reductions in mEPSC frequency in Trem2-/- mice (C) with no change in mEPSC 
amplitude. (D) Staining for synaptophysin (green) and PSD95 (red) was used to assess synapse number in 
1-month-old Trem2+/+ and Trem2-/- mice. (E) In CA1 stratum radiatum, there was a significant reduction in 
the number of synaptophysin+ puncta and a trend toward a reduction in apposed synaptic elements, as 
measured by PSD95+ puncta within 0.5μm of synaptophysin+ puncta. (F) Synaptic changes were also 
investigated in other regions of the mouse brain. (G) In layer V of the motor cortex, there was a significant 
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reduction in synaptophysin+ puncta, a strong trend toward a reduction in PSD95+ puncta and a significant 
decrease in apposed synaptic elements. (H) Western blots were performed on synaptosome enriched 
fractions isolated from whole brains of 1-month-old Trem2+/+ and Trem2-/- mice. (I) Within these 
synaptosomal fractions, there was no change in the abundance of synaptophysin or (J) PSD95 protein 
levels.  * (p<0.05), ** (p<0.01), *** (p<0.001) 
 
Figure S1. (A) Enrichment of synaptosomal proteins was validated in lysates prepared from synaptosomal 
isolations from Trem2+/+ and Trem2-/- mouse brains (synaptosome enriched) relative to whole protein 
lysates (S1). (B) Western blots were performed on synaptosome enriched fractions to assess protein levels 
of (C) synapsin, (D) NR2B and (E) NR2A. 
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Figure 2. TREM2 deficient microglia contain more engulfed synaptic material. (A) Confocal images of 
microglia (Iba1, red) and PSD95 (green) were acquired in layer V of the motor cortex. Images were 
thresholded and binary images were used to reconstruct individual microglia and PSD95 that was 
internalized within the microglial cell volume (indicated by white arrows). (B) The percent of Iba1+ cell 
volume that contained PSD95+ elements was significantly increased in layer V of the motor cortex in 
Trem2-/- mice relative to Trem2+/+ controls at 1 month of age. (C) There were no differences in internalized 
PSD95 volume in CA1 stratum radiatum. * (p<0.05) 
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Figure S2. (A) Primary microglia were isolated from littermate Trem2+/+ and Trem2-/- pups, cells were 
labeled with CellTracker (blue) and then exposed to Trem2+/+ pHrodo conjugated synaptosomes (red) for 
24 hours. Cells were either fixed (24hr) or switched to fresh media and fixed after an additional 16hr (24hr 
+ 16hr) and stained with PSD95 (green). White arrows indicate internalized synaptosomes and yellow 
arrows internalized synaptosomes which also co-localized with PSD95. (B) There was no significant effect 
of Trem2 genotype on the percent of microglial volume comprised of isolated synaptosomes after 24 
hours or (C) the percent of internalized PSD95 signal that was degraded after an additional 16hr. (D) qPCR 
was used to assess gene expression levels of complement components. (E) Western blots were performed 
on cortical lysates to evaluate levels of C1q protein expression relative to GAPDH. (F) Trem2+/+ microglia 
were cultured and exposed to pHrodo conjugated synaptosomes isolated from brains of 1-month-old 
Trem2+/+ or Trem2-/- mice and the percent internalized synaptosome volume quantified after 24 hours as 
in (A). 
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Figure 3. TREM2 is required for establishing appropriate microglial size, territory and number. (A) 
Morphology of individual microglia from 1-month-old Trem2+/+ and Trem2-/- mice was quantified (B) using 
Scholl and hull and circle analyses. (C) In layer V of the motor cortex, there was a significant increase in the 
total number of intersections in Trem2-/- microglia identified using Sholl analysis, with (D) no change in the 
number of primary branches or (E) the mean number of branches intersecting with each Sholl radius. (F) 
The length of the longest process was significantly increased in Trem2-/- microglia. (G) Hull and circle 
analysis identified no changes in microglial branch distribution in Trem2-/- microglia as measured by 
circularity, (H) a ratio of the minimum to maximum radii that could be drawn through the convex hull, or 
(I) the ratio of the area of the convex hull to its circumscribing circle. (J) The average area of the convex 
hull containing Trem2-/- microglia was significantly larger than Trem2+/+ microglia. (K) Microglial cell bodies 
were identified and used as seeds to produce Voronnoi tessellations to estimate the territory of individual 
microglia across the cortex and hippocampus. (L) The average size of these territories was quantified (M) 
along with the territory variance, calculated as the coefficient of variance for all the microglial territories 
defined within a given brain region for each animal. (N) The number of Iba1+ microglia was quantified 
across the cortex and hippocampus. (O) The number of internalized PSD95+ elements was quantified per 
microglia across the indicated brain regions and Trem2-/- data normalized to Trem2+/+ results within each 
region. Asterisks indicate results which were significantly different from 1. (P) The number of PSD95+ 
elements per cell was normalized to the difference in microglial density between Trem2+/+ and Trem2-/- 
mice in each brain region, determined from the quantification performed in (N). Asterisks indicate results 
which are significantly different from 1. Statistical results of 2-way ANOVAs are indicated, where 
significant, above graphs.* (p<0.05), ** (p<0.01), *** (p<0.001)   
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Figure S3. (A) Voronoi analysis was used to quantify the territory mean and (B) variance across brain 
regions outside of the cortex and hippocampus. (C) Microglial number was quantified from slide scans of 
Iba1 immunohistochemistry on sagittal slices from Trem2+/+ and Trem2-/- mice (D) across the brain 
regions indicated. ELISAs were performed to assess protein levels of (E) CSF1 and (F) IL34 protein in 
Trem2+/+ and Trem2-/- cortical lysates. Statistical results of 2-way ANOVAs are indicated, where 
significant, above graphs.* (p<0.05), *** (p<0.001) 
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Figure 4. TREM2 deficiency increases astrocyte uptake of synapses. (A) Astrocytes were identified using 
immunohistochemistry for Aldhl1. Images were thresholded and quantification performed on binary 
images to assess PSD95 internalized within Aldhl1+ cells, indicated by white arrows. (B) There was a 
significant increase in the percent volume of astrocytes containing PSD95 in 1-month-old Trem2-/- mice 
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relative to controls in layer V of the motor cortex and (C) CA1 stratum radiatum. (D) The percent of Iba1 
and Aldhl1+ cells that contained PSD95+ signal was quantified. (E) The volume of glia across the fields 
imaged for synaptic element quantification in motor cortex layer V was compared. (F) The internalized 
PSD95 volume within each glial subtype was quantified per field. * (p<0.05), *** (p<0.001) 
 
Figure S4.  (A) Trem2+/+ astrocytes were cultured, labeled with CellTracker (cyan) and exposed to media 
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from Trem2+/+ or Trem2-/- microglia or unconditioned media for 6 hours. pHrodo conjugated 
synaptosomes (red) isolated from Trem2+/+ mice were added to the media at time 0. Representative 
images were taken 24 hours after addition of synaptosomes. (B) Cells were imaged at the indicated time 
points and the percent of synaptosome volume within astrocytes was quantified and normalized to the 
percent volume of synaptosomes in astrocytes exposed to unconditioned media at 24 hours. (C) The total 
volume of microglia, labeled with Iba1, and astrocytes, labeled with Aldhl1, was quantified across each 
field. There was no significant difference in the volume occupied by astrocytes with Trem2 genotype. (D) 
qPCR was used to evaluate gene expression of astrocyte-derived factors that promote synaptogenesis and 
synaptic maturation in cortical lysates, which were normalized to gene expression of Aldhl1. Statistical 
results of 2-way ANOVAs are indicated above graphs. T-tests between Trem2+/+ media and unconditioned 
media conditions are indicated above each time point in black and Trem2-/- media and unconditioned 
media conditions in gray. * (p<0.05), ** (p<0.01), *** (p<0.001), ns (not significant) 
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Figure 5. Effects of Trem2 genotype are largely normalized at 4 months of age. (A) Synapse number was 
assessed in 4-month-old Trem2+/+ and Trem2-/- mice using immunohistochemistry for synaptophysin (red) 
and PSD95 (green). (B) There was no significant effect of TREM2 deficiency on synapse number in layer V 
of the motor cortex or (C) in CA1 stratum radiatum. (D) The volume of microglia (Iba1, red) that contained 
PSD95+ elements (green) was assessed. White arrows indicate internalized PSD95 and blue arrows large 
PSD95+ inclusions (>10px2) which were quantified in (E) layer V of the motor cortex and (F) in CA1 stratum 
radiatum. In layer V of the motor cortex (G) measures of microglial size were assessed by determining the 
average area of the convex hull using the hull and circle algorithm and (H) by assessing the distance to the 
longest process using Sholl analysis. (I) Territory mean and (J) variance were quantified from Voronnoi 
tessellations and (K) microglial density was determined. In (G) – (K), the lines represent the values 
quantified in 1-month-old Trem2+/+ and Trem2-/- mice. In these analyses, 2-way ANOVAs were performed 
across age and genotype. (L) Synaptic engulfment in astrocytes was assessed by immunohistochemistry 
for Aldhl1 (red) and PSD95 internalized within these cells (green). (M) The percent of astrocyte volume 
containing PSD95+ elements was quantified in layer V of the motor cortex and (N) in CA1 stratum 
radiatum. Statistical results of 2-way ANOVAs are indicated, where significant, above graphs. * (p<0.05), 
** (p<0.01), *** p<0.001) 
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Figure S5. (A) ELISAs were used to quantify IL34 and CSF1 protein levels in Trem2+/+ and Trem2-/- cortical 
lysates at 1 and 4 months of age. (B) qPCR was used to measure gene expression levels of astrocytic genes 
involved in synapse formation and maturation relative to gene expression of Aldhl1 in cortical lysates 
from 4-month-old Trem2+/+ and Trem2-/- mice. * (p<0.05), ** (p<0.01) 
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Figure 6. TREM2 deficiency alters synapse number in 4-month-old mice fed a high fat diet. Trem2+/+ and 
Trem2-/- mice were fed a standard diet until 1 month of age and then were either maintained on a 
standard diet (SD) or administered a high fat diet (HFD) until sacrifice at 4 months of age. (A) In layer V of 
the motor cortex, synaptophysin+ element number, (B) PSD95+ element number and (C) apposed 
synaptic elements were quantified. (D) The percent of synaptophysin+ puncta that were within 0.5μm of 
PSD95+ puncta and (E) the percent of PSD95+ elements within 0.5μm of synaptophysin+ puncta were also 
assessed. In layers II and III of motor cortex, (F) the number of synaptophysin+ puncta, (G) the number of 
PSD95+ puncta, (H) apposed synaptic elements, (I) the percent of synaptophysin+ puncta within 0.5μm of 
PSD95+ puncta and (J) the percent of PSD95+ elements within 0.5μm of synaptophysin+ puncta were 
quantified. Similar analyses were performed In CA1 stratum radiatum, quantifying (K) the number of 
synaptophysin+ puncta, (L) the number of PSD95+ puncta, (M) apposed synaptic elements, (N) the 
percent of synaptophysin+ puncta within 0.5μm of PSD95+ puncta and (O) the percent of PSD95+ 
elements within 0.5μm of synaptophysin+ puncta. Statistical results of 2-way ANOVAs are indicated, 
where significant, above graphs. ns (not significantly different), * (p<0.05), ** (p<0.01), *** (p<0.001) 
